March 26, 2020March 27, 2020
FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS

The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS ( ... Read more
March 31, 2020March 30, 2020
Calm, Care, and Prayer Will Help During the Coronavirus Crisis

No one needs to be reminded of the pandemic we’re in the midst of. We live it every day. The novel coronavirus has attacked ... Read more
March 31, 2020March 27, 2020
How to Cope and Thrive During a Challenging Time

Living through this unique time is nothing like I’ve ever experienced before. There’s so much doom and gloom around lately. I don’t know about ... Read more
March 31, 2020March 31, 2020
Canada Rules EHP-101, Potential Cannabidiol Treatment, Not Controlled Substance

EHP-101, a cannabidiol-derived investigational therapy being developed by Emerald Health Pharmaceuticals (EHP) to treat multiple sclerosis (MS), is not a controlled substance in Canada, the company ... Read more
March 31, 2020March 31, 2020
Bile Acid Supplements May Ease Symptoms of Progressive MS

Multiple sclerosis (MS) patients have lower than usual levels of molecules called bile acids circulating in their blood, a study found. These molecules, produced in ... Read more
March 30, 2020March 30, 2020
MS News that Caught My Eye Last Week: COVID-19 and MS, Zeposia Approved, Talk Therapy, Temelimab Trial Postponed

As the COVID-19 pandemic swirls around us, we will continue to provide our readers with information about the novel coronavirus and many other MS ... Read more